Zenas BioPharma, Inc. · NASDAQ:ZBIO

Zenas BioPharma, Inc. financial statements

Zenas BioPharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022
Revenue10.0M5.00M50.0M0
Cost of revenue56.0K139.1M113.0K61.7M
Gross profit10.0M-134.1M50.0M-61.7M
Research and development168.1M139.1M60.0M62.7M
Selling, general and administrative53.3M28.8M17.1M12.8M
Operating income-383.1M-163.9M-37.1M-76.2M
Depreciation and amortization56.0K137.0K113.0K78.0K
EBITDA-383.0M-163.8M-37.0M-76.1M
Interest expense7.33M0
Income before tax-377.8M-156.6M-36.8M-119.3M
Income tax-79.0K429.0K301.0K
Net income-377.7M-157.0M-37.1M-119.3M
Earnings per share, basic-8.44-11.89-24.25-3.11
Earnings per share, diluted-8.44-11.89-24.25

Balance sheet

LineFY2025FY2024FY2023FY2022
Cash and equivalents110.6M319.7M56.9M67.2M
Short-term investments232.6M31.0M0
Current assets351.2M355.9M59.8M68.4M
Property, plant and equipment34.0K185.0K193.0K
Total assets383.6M370.0M68.2M74.6M
Accounts payable7.11M17.1M5.40M5.82M
Current liabilities62.6M57.3M23.3M26.0M
Long-term debt78.6M20.3M
Total debt78.6M1.00M21.1M1.53M
Total liabilities141.5M57.5M43.8M266.9M
Shareholders' equity242.1M312.5M-225.7M-192.3M
Shares outstanding54.5M41.8M1.58M38.3M

Cash flow

LineFY2025FY2024FY2023FY2022
Cash from operations-172.3M-119.7M-30.5M-65.7M
Capital spending-18.0K-131.0K-17.0K-2.20M
Free cash flow-172.4M-119.8M-30.5M-67.8M
Cash from investing-251.9M-30.6M-17.0K-2.20M
Cash from financing215.3M413.0M20.1M59.4M
Share buybacks276.0K
Change in cash-209.2M262.9M-10.4M-8.50M